NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.90+0.08 (+9.83%)
Close on Nov 18, 2026Market cap $104.20MP/E –Yield –
NovaBridge Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NovaBridge Biosciences's operating cash flow for the twelve months ending Dec 31, 2020 was CN¥433.56M. For fiscal 2023 it was -CN¥1.30B. The highest annual figure on record is CN¥433.56M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -CN¥1.30B | – |
| FY2022 | Dec 31, 2022 | -CN¥1.10B | – |
| FY2021 | Dec 31, 2021 | -CN¥973.09M | -324.4% |
| FY2020 | Dec 31, 2020 | CN¥433.56M | – |
| FY2019 | Dec 31, 2019 | -CN¥867.98M | – |
| FY2018 | Dec 31, 2018 | -CN¥280.71M | – |
| FY2017 | Dec 31, 2017 | -CN¥252.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2020 | Dec 31, 2020 | CN¥1.02B | – |
| Q4 FY2019 | Dec 31, 2019 | -CN¥215.99M | – |
See a number that looks wrong?